Cargando…

CRISPR/Cas9 therapeutics: progress and prospects

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene-editing technology is the ideal tool of the future for treating diseases by permanently correcting deleterious base mutations or disrupting disease-causing genes with great precision and effici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tianxiang, Yang, Yanyan, Qi, Hongzhao, Cui, Weigang, Zhang, Lin, Fu, Xiuxiu, He, Xiangqin, Liu, Meixin, Li, Pei-feng, Yu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841506/ https://www.ncbi.nlm.nih.gov/pubmed/36646687 http://dx.doi.org/10.1038/s41392-023-01309-7

Ejemplares similares

In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
por: Behr, Matthew, et al.
Publicado: (2021)

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023)

Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies
por: Kang, Xianhui, et al.
Publicado: (2023)

Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System
por: Wang, Ling, et al.
Publicado: (2017)

Generation of VDR Knock-Out Mice via Zygote Injection of CRISPR/Cas9 System
por: Zhang, Tao, et al.
Publicado: (2016)

Uricase-deficient rat is generated with CRISPR/Cas9 technique
por: Yu, Yun, et al.
Publicado: (2020)

CRISPR–Cas9 Based Therapeutics: Not So Fast
Publicado: (2015)

The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease
por: Zou, Yulin, et al.
Publicado: (2021)

CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
por: Alkanli, Suleyman Serdar, et al.
Publicado: (2022)

Lysine Malonylation and Its Links to Metabolism and Diseases
por: Zou, Lu, et al.
Publicado: (2023)

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
por: Zheng, Ruixuan, et al.
Publicado: (2023)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Applications and Prospects of CRISPR/Cas9-Mediated Base Editing in Plant Breeding
por: Li, Yizhen, et al.
Publicado: (2023)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects
por: Tripathi, Shyam, et al.
Publicado: (2022)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR/Cas9—A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects
por: Ahmad, Irshad
Publicado: (2022)

Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods
por: Sun, Dan, et al.
Publicado: (2017)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
por: Bhat, Ajaz A., et al.
Publicado: (2022)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Mutagenesis of seed storage protein genes in Soybean using CRISPR/Cas9
por: Li, Chenlong, et al.
Publicado: (2019)

Application of CRISPR/Cas9 for biomedical discoveries
por: Riordan, Sean M., et al.
Publicado: (2015)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Bidirectional Promoter-Based CRISPR-Cas9 Systems for Plant Genome Editing
por: Ren, Qiurong, et al.
Publicado: (2019)

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
por: Nie, Dengyun, et al.
Publicado: (2022)

Rational Design of Poly(disulfide)s as a Universal Platform for Delivery of CRISPR-Cas9 Machineries toward Therapeutic Genome Editing
por: Guo, Jiajing, et al.
Publicado: (2021)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
por: Wang, Yanlin, et al.
Publicado: (2018)

Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases
por: Xue, Qianqian, et al.
Publicado: (2022)

CRISPR/Cas9-mediated point mutations improve α-amylase secretion in Saccharomyces cerevisiae
por: Wang, Yanyan, et al.
Publicado: (2022)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
por: Zhu, Xinglong, et al.
Publicado: (2023)

CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
por: Khan, Faheem Ahmed, et al.
Publicado: (2016)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvneo2u0l4lbnmc6bu05i4k2oe